Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le Bris

Showing results (371-380 of 387) with videos related to

Pageof 39
Sort By:
Haematologica|January 12, 2019
FLT3 ligand plasma levels in acute myeloid leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
The Lancet. Haematology|May 28, 2023
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 studyPierre Peterlin, Yannick Le Bris, Pascal Turlure, et al.
Plos One|May 11, 2011
Pan-European distribution of white-nose syndrome fungus (Geomyces destructans) not associated with mass mortalitySébastien J Puechmaille, Gudrun Wibbelt, Vanessa Korn, et al.
Acta Oncologica (Stockholm, Sweden)|October 28, 2020
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamidePatrice Chevallier, Ana Berceanu, Pierre Peterlin, et al.
Haematologica|May 15, 2025
Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND studyGabriel Brisou, Jérôme Paillassa, Sophie Bernard, et al.
Blood|April 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, et al.
Haematologica|April 4, 2020
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life studySophie Vantyghem, Pierre Peterlin, Sylvain Thépot, et al.
Nature Genetics|May 2, 2018
The Rosa genome provides new insights into the domestication of modern rosesOlivier Raymond, Jérôme Gouzy, Jérémy Just, et al.
Blood Advances|March 5, 2021
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM studyDamien Luque Paz, Jérémie Riou, Emmanuelle Verger, et al.
The New England Journal of Medicine|February 12, 2025
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory MyelomaSimon J Harrison, Cyrille Touzeau, Nicolas Kint, et al.
Pageof 39

Showing results (371-380 of 387) with videos related to

Sort By:
Pageof 39
Haematologica|January 12, 2019
FLT3 ligand plasma levels in acute myeloid leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
The Lancet. Haematology|May 28, 2023
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 studyPierre Peterlin, Yannick Le Bris, Pascal Turlure, et al.
Plos One|May 11, 2011
Pan-European distribution of white-nose syndrome fungus (Geomyces destructans) not associated with mass mortalitySébastien J Puechmaille, Gudrun Wibbelt, Vanessa Korn, et al.
Acta Oncologica (Stockholm, Sweden)|October 28, 2020
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamidePatrice Chevallier, Ana Berceanu, Pierre Peterlin, et al.
Haematologica|May 15, 2025
Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND studyGabriel Brisou, Jérôme Paillassa, Sophie Bernard, et al.
Blood|April 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, et al.
Haematologica|April 4, 2020
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life studySophie Vantyghem, Pierre Peterlin, Sylvain Thépot, et al.
Nature Genetics|May 2, 2018
The Rosa genome provides new insights into the domestication of modern rosesOlivier Raymond, Jérôme Gouzy, Jérémy Just, et al.
Blood Advances|March 5, 2021
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM studyDamien Luque Paz, Jérémie Riou, Emmanuelle Verger, et al.
The New England Journal of Medicine|February 12, 2025
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory MyelomaSimon J Harrison, Cyrille Touzeau, Nicolas Kint, et al.
Pageof 39